Clinical trial
DepoCyt Therapy in Patients With Neoplastic Meningitis From Lymphoma or a Solid…
NCT00029523 · Pacira Pharmaceuticals, Inc, Industry · Completed
Key facts
| NCT number | NCT00029523 |
|---|---|
| Title | DepoCyt Therapy in Patients With Neoplastic Meningitis From Lymphoma or a Solid Tumor |
| Official title | A Randomized Clinical Study to Determine the Patient Benefit and Safety of Depocyt (Cytarabine Liposome Injection) for the Treatment of Neoplastic Meningitis |
| Lead sponsor | Pacira Pharmaceuticals, Inc, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Meningeal Neoplasms |
| Intervention type | Drug |
| Interventions | Intrathecal (injected into the spinal fluid) DepoCyt, Intrathecal methotrexate, Intrathecal cytarabine (also known as ara-C) |
| Enrollment | 100 |
| Start date | Apr 1, 2001 |
| Completion | Nov 1, 2004 |
| First posted | Jan 16, 2002 |
| Last update posted | Feb 28, 2007 |
| Countries | Canada, United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: